Thomas MS Wolever, Jennie C Brand-Miller, John Abernethy, Arne Astrup, Fiona Atkinson, Mette Axelsen,
Inger Bjrck, Furio Brighenti, Rachel Brown, Audrey Brynes, M Cristina Casiraghi, Murielle Cazaubiel,
Linda Dahlqvist, Elizabeth Delport, Gareth S Denyer, Daniela Erba, Gary Frost, Yvonne Granfeldt, Shelagh Hampton,
Valerie A Hart, Katja A Hatnen, C Jeya Henry, Steve Hertzler, Sarah Hull, Johann Jerling, Kelly L Johnston,
Helen Lightowler, Neil Mann, Linda Morgan, Leonora N Panlasigui, Christine Pelkman, Tracy Perry,
Andreas FH Pfeiffer, Marlien Pieters, D Dan Ramdath, Rayna T Ramsingh, S Daniel Robert, Carol Robinson,
Essi Sarkkinen, Francesca Scazzina, Dave Clark D Sison, Birgitte Sloth, Jane Staniforth, Niina Tapola, Liisa M Valsta,
Inge Verkooijen, Martin O Weickert, Antje R Weseler, Paul Wilkie, and Jian Zhang
KEY WORDS
Clinical trial, humans, dietary carbohydrate,
glycemic index, glucose, methodology
INTRODUCTION
The glycemic index (GI) is a measure of the blood glucoseraising ability of the available carbohydrate in foods defined as
Am J Clin Nutr 2008;87(suppl):247S57S. Printed in USA. 2008 American Society for Nutrition
247S
ABSTRACT
Background: Many laboratories offer glycemic index (GI) services.
Objective: We assessed the performance of the method used to
measure GI.
Design: The GI of cheese-puffs and fruit-leather (centrally provided) was measured in 28 laboratories (n 311 subjects) by using
the FAO/WHO method. The laboratories reported the results of their
calculations and sent the raw data for recalculation centrally.
Results: Values for the incremental area under the curve (AUC)
reported by 54% of the laboratories differed from central calculations. Because of this and other differences in data analysis, 19% of
reported food GI values differed by 5 units from those calculated
centrally. GI values in individual subjects were unrelated to age, sex,
ethnicity, body mass index, or AUC but were negatively related to
within-individual variation (P 0.033) expressed as the CV of the
AUC for repeated reference food tests (refCV). The betweenlaboratory GI values (mean SD) for cheese-puffs and fruit-leather
were 74.3 10.5 and 33.2 7.2, respectively. The mean laboratory
GI was related to refCV (P 0.003) and the type of restrictions on
alcohol consumption before the test (P 0.006, r2 0.509 for
model). The within-laboratory SD of GI was related to refCV (P
0.001), the glucose analysis method (P 0.010), whether glucose
measures were duplicated (P 0.008), and restrictions on dinner the
night before (P 0.013, r2 0.810 for model).
Conclusions: The between-laboratory SD of the GI values is 9.
Standardized data analysis and low within-subject variation (refCV
30%) are required for accuracy. The results suggest that common
misconceptions exist about which factors do and do not need to be
controlled to improve precision. Controlled studies and cost-benefit
analyses are needed to optimize GI methodology. The trial was
registered at clinicaltrials.gov as NCT00260858.
Am J Clin
Nutr 2008;87(suppl):247S57S.
248S
WOLEVER ET AL
TABLE 1
Composition of the test foods
Cheese Puffs
Fruit Leather3
Weight
Fat
Protein
Total CHO1
Dietary fiber
Available CHO
82.4
63.6
15.1
0.0
6.1
0.0
54.5
54.5
4.5
4.5
50.0
50.0
CHO, carbohydrate.
Pirates Booty, Roberts American Gourmet, Sea Cliff, NY.
3
Original Sweet Strawberry flavor, Stretch Island Fruit Co, Allyn, WA.
2
Kingdom (CJH and HL); the Department of Human Nutrition, Ohio State
University, Columbus, OH (SHertzler and PW); the Nutrition and Health
Section, Leatherhead Food International, Surrey, United Kingdom (SHull);
the Department of Nutrition, Northwest University, Potchefstroom, South
Africa (JJ and MP); the International Diabetes Institute, Melbourne, Victoria,
Australia (NM and CR); Reading Scientific Services, Ltd, Reading, Berks,
United Kingdom (VAH and JS); the College of Home Economics, University
of the Philippines, Diliman, The Philippines (LP and DCDS); the Department
of Exercise and Nutrition Sciences, University at Buffalo, Buffalo, NY (CP);
the Department of Clinical Nutrition, German Institute of Human Nutrition
(DIFE) Potsdam-Rehbruecke, Nuthetal, and the Department of Endocrinology, Diabetes and Nutrition, Charit-University-Medicine Berlin, Germany
(AFHP and MOW); the Biochemistry Unit, Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St
Augustine, Trinidad and Tobago (DDR and RTR); the Program in Dietetics,
School of Health Sciences , Health Campus, Universiti Sains Malaysia,
Kelantan, Malaysia (SDR); Oy Foodfiles Ltd, Kuopio, Finland (ES and NT);
NutriScience BV, Maastricht, Netherlands (IV and AW); and the Institute of
Nutrition and Food Safety, Chinese Center for Disease Control and Prevention, Beijing, China (JZ).
2
Presented at an ILSI Europe workshop titled Glycemic Response and
Health, held in Nice, France, on 6-8 December 2006.
3
Supported by Glycaemic Index Testing, Inc, Toronto, ON, Canada;
Sydney University GI Research Services, University of Sydney; ILSI Europe, Brussels, Belgium; Biofortis; Department of Human Nutrition, University of Otago; Philippine Council for Health Research and Development,
Department of Science and Technology, University of the Philippines; GI
Expert Laboratory, Lund, Sweden; GI Foundation of South Africa; GI Laboratories, Inc; GI Testing Services, Oxford Brookes University; Hammersmith Food Research; University of Surrey; International Diabetes Institute;
Leatherhead Food International; Ministry of Agriculture and Forestry, Academy of Finland, National Public Health Institute, Finland; Reading Scientific
Services, Ltd; NutriScience BV; Oy Foodfiles, Ltd; University of Parma;
Universiti Sains Malaysia; and University of the West Indies.
4
Address reprint requests to ILSI Europe. E-mail: publications@
ilsieurope.be.
5
Address correspondence to T Wolever, Department of Nutritional Sciences, University of Toronto, Toronto, Ontario M5S 3E2, Canada. E-mail:
thomas.wolever@utoronto.ca.
variation of the means and SDs of GI values measured by different laboratories around the world and to determine the extent
to which sources of methodologic variation may explain the
interlaboratory variation of GI means and SD.
249S
Males/females (n)
Age (y)
Height (cm)
Weight (kg)
BMI (kg/m2)
Underweight [n (%)]
Ideal weight [n (%)]
Overweight [n (%)]
Obese [n (%)]
Reference AUC (mmol min/L)3
Reference CV (%)
Glycemic index (%)4
White
(n 241)
Other
(n 70)1
101/140
30.0 0.72
172 1
69.9 0.9
23.4 0.2
4 (2)
176 (73)
51 (21)
10 (4)
206 5
22.3 1.0
53.1 1.2
26/44
28.7 1.1
163 1
60.3 1.4
22.6 0.4
2 (3)
43 (61)
21 (30)
4 (5)
258 13
23.1 2.9
53.8 2.4
NS
NS
0.0001
0.0001
0.090
NS
0.0001
NS
NS
250S
WOLEVER ET AL
150 subjects at these laboratories, 30 reported taking medications, the most common of which was the oral contraceptive pill
(n 18). Other medications were angiotensin-converting enzyme inhibitors (n 3), nonsteroidal anti-inflammatory agents
(n 3), thyroid replacement therapy (n 2), and one subject
each for aspirin, -blocker, anti-histamine, antibiotic, and a
triptan for migraines. Information about the subjects smoking
habits was provided by 12 laboratories, and of the 136 subjects
involved, 3 were smokers. At 26 of the 28 participating laboratories, all subjects (n 275) tested both test foods. In the 27th
FIGURE 2. Mean blood glucose responses elicited by the reference food, cheese puffs (), and fruit leather () in 24 laboratories (n 271 subjects) that
used glucose (F) as the reference food (left) and in 4 laboratories (n 70 subjects) that used white bread (E) as the reference food.
251S
and fruit leather, respectively, were 74.3 10.5 (Figure 4A) and
33.2 7.2 (Figure 4B). The SDs of the GI values in the 28
laboratories varied from 14 to 48 for cheese puffs (meanSD,
27.5 9.0; Figure 4C) and from 9 to 25 for fruit leather (14.7
4.2, Figure 4D).
Methodologic variables related to the test meal included the
type of reference food used, the number of reference food tests
done by each subject, and the nature of the drink given with the
test meal. By ANOVA, the variation in these factors was not
associated with any significant differences in adjusted reference
AUC, refCV, mean GI, or SD of GI (Table 3).
The laboratories varied in the methods used for blood sampling and glucose analysis. The laboratories (n 4) that took 2
fasting blood samples and used the average measure to calculate
GI tended to have a lower mean refCV and mean GI (not significant) and a significantly lower SD (Table 4). Duplicate measurement of glucose also tended to be associated with reduced
variation, although the difference was not significant. The 11
laboratories that did any duplication (duplicate blood samples,
duplicate measurements, or both) had a significantly lower SD
than did the 17 laboratories that did not. Use of an enzymatic
method to measure glucose tended to be associated with higher
refCV and SD of GI than the other analytic methods, although the
differences were not statistically significant (Table 4).
252S
WOLEVER ET AL
TABLE 3
Effect of test meal variables on outcomes1
Reference food
Glucose (n 24)
White bread (n 4)
Number of reference tests per subject
1 (n 2)
2 (n 8)
3 (n 18)
Drink type
Not specified (n 2)
Water only (n 20)
Tea or coffee allowed (n 6)
Reference AUC
Reference CV
Mean GI
SD of GI
DV
mmol min/L
213 12
230 8
22.0 1.2
26.2 5.0
58.5 1.6
62.9 5.6
22.1 1.0
26.1 6.8
1
2
265 79
199 21
217 10
22.3 3.3
22.6 1.3
65.9 3.6
59.3 3.5
58.3 1.8
23.3 1.4
24.4 2.9
21.8 1.5
215 7
210 12
232 26
21.4 3.6
23.6 1.6
19.7 1.8
55.1 2.4
54.4 1.7
51.0 2.7
20.7 0.1
22.4 1.4
17.0 1.4
1
0
2
1
All values are x SEM. The number of laboratories is indicated by n. Shown is the incremental area under the curve (AUC) for the reference food (glucose
or white bread); values for white bread were adjusted by dividing by 0.71. Reference CV is the CV (100SD/x ) of the reference AUC values for each subject.
DV is the value of the dummy variable assigned to the method variable for step-wise multiple regression analysis. GI, glycemic index.
values (Table 5). The length of the fasting time did not appear to have
any significant effect.
By univariate regression analysis, the mean GI value of the
laboratories was significantly related to 2 factors: laboratory
mean refCV (r 0.556, P 0.003; Figure 5A) and the type of
restriction placed on exercise before the test (exercise number: 0
no restriction, 1 no activity at all, 2 no unusual activity;
r 0.495, P 0.010). By multiple regression analysis, refCV
(P 0.006) and exercise number (P 0.017) together explained
46% of the variation in mean GI (ie, the coefficient of determination: r2 0.463, r 0.681, P 0.001). However, the combination of refCV (P 0.001) and the restriction placed on
TABLE 4
Effect of blood sampling and glucose measurement methods on outcomes1
Reference AUC
Reference CV
Mean GI
SD of GI
DV
mmol min/L
214 11
220 15
23.4 1.4
18.1 0.9
54.5 1.5
49.1 1.3
22.3 1.1a
14.1 0.7b
214 12
213 21
212 27
23.3 1.5
26.5 6.3
19.5 2.4
54.6 1.9
54.6 1.2
51.7 2.3
21.9 1.5
22.1 6.7
17.8 1.2
214 13
217 15
23.9 1.6
20.6 1.8
55.2 2.0
51.5 1.4
23.4 1.3a
17.5 1.4b
0
1
209 21
220 18
242 18
185 18
24.9 2.7
21.3 2.3
22.9 2.6
20.3 1.4
55.1 2.6
52.5 1.9
51.8 4.3
55.5 2.5
24.6 2.1
20.8 2.0
18.6 2.4
18.3 1.4
1
2
3
1, 3
The number of laboratories is indicated by n. Shown is the incremental area under the curve (AUC) for the reference food (glucose or white bread); values
for white bread were adjusted by dividing by 0.71. Reference CV is the CV (100SD/x ) of the reference AUC values for each subject. DV is the value of the
dummy variable assigned to the method variable for step-wise multiple regression analysis. GI, glycemic index. Means not sharing the same superscript letter
are significantly different, P 0.05.
2
Enzymatic tests included Analox GM9D Glucose Direct analyser (Waltham, MA) (n 1). Hemocue is Hemocue 201 analyzer, Hemocue AB
(Angelholm, Sweden). Glucometers used included Glucotrend (Roche Diagnostics, Basel, Switzerland) (n 1), Lifescan Surestep (Milpitas, CA) (n 1),
Ascensia (Bayer Diagnostics, Tarrytown, NY) (n 2), and Medisense (Abbott Laboratories, Abbott Park, IL) (n 1). One laboratory, which measured fasting
glucose by meter (type not specified) and postprandial glucose by using YSI, was placed into the Glucometer category. YSI is Model 2300 STAT glucose
analyzer (YSI Inc, Yellow Springs, OH). The dummy variable used for YSI was 1 for correlations with mean GI and 3 for correlations with SD of GI.
There was wide variation in the restrictions placed on the subjects diets and activities before the test in different laboratories.
Allowing the subjects to do usual, but not unusual, physical activities (n 5 laboratories) for 24 h before the test was associated with
significantly lower mean GI and a tendency toward reduced variation than that reported by the 10 laboratories that did not place any
restrictions on the subjects activities before the test. The results for
the 13 laboratories that did not allow any vigorous physical activity
whatsoever were intermediate (Table 5). Not allowing subjects to
consume alcoholic beverages for 24 h before the test and restricting
the type of dinner consumed or providing a standardized dinner were
associated with nonsignificant reductions in the mean and SD of GI
253S
Reference CV
Mean GI
SD of GI
DV
mmol min/L
229 16
185 23
216 15
24.2 2.3
20.5 2.3
22.2 1.8
58.5 2.2a
50.1 1.2b
51.4 2.0a,b
26.0 2.0
19.4 1.9
21.4 1.8
0
2
1
217 13
208 18
219 16
21.2 2.7
20.4 2.2
24.5 1.7
60.0 3.0
53.6 2.1
50.5 1.5
22.5 0.9
22.6 1.8
18.0 1.6
0
1
2
215 9
214 19
217 28
24.5 2.3
21.9 1.5
20.1 3.1
55.8 2.6
52.4 1.7
52.3 3.4
24.2 1.9
19.2 1.3
18.9 2.8
0
1
2
208 15
229 5
23.6 1.4
20.9 2.4
54.1 1.9
53.1 2.0
21.7 1.3
20.0 2.2
0
1
Vigorous activity
No restriction (n 10)
No unusual (n 5)
None at all (n 13)
Alcohol consumption3
Not specified (n 5)
None for 12 h (n 9)
None for 24 h (n 14)
Dinner the night before4
No restriction (n 11)
Restrictions (n 12)
Meal provided (n 5)
Length of fasting5
Fixed time (n 18)
None or range (n 10)
DISCUSSION
1
The number of laboratories is indicated by n. Shown is the incremental area under the curve (AUC) for the reference food (glucose or white bread); values
for white bread were adjusted by dividing by 0.71. Reference CV is the CV (100SD/x ) of the reference AUC values for each subject. DV is the value of the
dummy variable assigned to the method variable for step-wise multiple regression analysis. GI, glycemic index. Means not sharing the same superscript letter
are significantly different, P 0.05.
2
No restriction includes laboratories stating there was no restriction (n 6) and laboratories not specifying (n 4). None at all includes laboratories that
did not allow subjects to undertake any vigorous activity for 3 d (n 1), 24 h (n 8), 18 h (n 1), or 12 h (n 3) before the test.
3
24 h includes laboratories that advised subjects to consume no alcohol for 24 h (n 12) or 48 h (n 1) and 1 laboratory that excluded subjects who
ever used alcohol.
4
Restrictions includes laboratories allowing subjects to self-select the dinner but advising them to always have the same dinner (n 4), to avoid high-fiber
foods (n 3), to avoid legumes (n 2), to have a high-carbohydrate, low-fat meal (n 2), and to have a high-carbohydrate, high-GI meal (n 1). The types
of meals provided to subjects included solid foods (n 3), liquid test meals (n 1), and white bread and water (n 1).
5
Fixed time includes laboratories that advised subjects to fast for 8 h (n 1), 10 h (n 9), or 12 h (n 8). None or range includes laboratories that did
not specify the length of fasting time (n 3) or advised subjects to fast for 10 12 h (n 6) or 10 14 h (n 1).
254S
WOLEVER ET AL
increase the resulting mean and SD. Thus, it has been recommended that outliers should be excluded (31). Values 2 SDs
above the mean are often considered to be outliers, a cutoff that
excludes 2.5% of normally distributed values. Because GI values
are not normally distributed, a cutoff of 2 SDs may not be considered conservative enough if it results in 2.5% of the values
being excluded. However, our results show that, despite a
skewed distribution, only 2.2% of individual values were 2
SDs above the mean (95% CI: 1.33.4%). Thus, 2 SDs above
the mean appears to be an appropriate definition of GI outliers.
Only 2 (0.3%) values were 2 SDs below the mean, and, because
GI values are skewed to the right, we did not consider it appropriate or necessary to exclude these values.
Within-individual variation in glycemic responses (laboratory
mean refCV) was positively related to the mean and the SD of GI
values. The implication of this is that a high refCV leads to bias
and imprecision of the resulting GI values. Previous work suggests that refCV is affected by the blood sampling schedule,
method of calculating AUC (42), capillary versus venous blood
sampling (32, 41), and the restrictions placed on the subjects diet
and activity the day before testing (43). Here, however, the only
factor significantly related to refCV was that subjects with a low
FIGURE 5. Determinants of variation in mean and SD of glycemic index (GI) values from the 26 laboratories with repeated reference tests. A: univariate
regression of mean GI on reference coefficient of variation (refCV). B: multiple regression of mean GI on refCV and restrictions on ethanol intake (EtOH). C:
univariate relation of SD of GI on refCV. D: multiple regression of SD of GI on refCV, method of glucose analysis (Mth), duplication (Dup), and nature of the
dinner the night before (Din).
The between-laboratory SD of GI values is 9 with no significant difference in mean GI between laboratories. Standardized data analysis and low within-subject variation (refCV
30%) are required for accuracy. The results suggest that common
misconceptions exist about which factors do and do not need to
be controlled to improve precision. Controlled studies and costbenefit analyses are needed to optimize GI methodology.
The contributions of the authors were as follows. TMSW: had full access
to all of the data in the study and takes responsibility for the integrity of the
data and the accuracy of the data analysis. The following letters identify the
types of contributions and are listed for each author. A: conception and design
of overall study; B: drafting and circulation of protocol, provision of central
foods, central data analysis; C: critical review of protocol (at each center;
design of procedures, acquisition of data, and calculation of results); D:
Drafting and revision of the manuscript; E: critical revision of the manuscript
for important intellectual content; F: obtained funding. TMS Wolever: A, B,
C, D, F; JC Brand-Miller: A, C, E, F; J Abernethy: C, E, F; A Astrup: C, E,
F; F Atkinson: C, E; M Axelsen: C, E, F; I Bjrk: C, E, F; F Brighenti: C, E,
F; R Brown: C, E; A Brynes: C, E; MC Casiraghi: C, E, F; M Cazaubiel: C,
E, F; L Dahlqvist: C, E; E Delport: C, E, F; GS Denyer: C, E; D Erba: C, E;
G Frost: C, E, F; Y Granfeldt: C, E; S Hampton: C, E, F; VA Hart: C,E; K
Hatnen: C, E; CJ Henry: C, E, F; S Hertzler: C, E, F; S Hull: C, E; J Jerling:
C, E, F; KL Johnston: C, E, F: H Lightowler: C, E; N Mann: C,E,F; L Morgan:
C, E, F; L Panlasigui: C, E, F; C Pelkman: C, E, F; T Perry: C, E, F; AFH
Pfeiffer: C, E, F; M Pieters: C, E; DD Ramdath: C, E, F; RT Ramsingh: C, E;
SD Robert: C, E, F; C Robinson: C,E; E Sarkkinen: C, E, F; F Scazzina: C,
E; DCD Sison: C, E; B Sloth: C, E; J Staniforth: C, E, F; N Tapola: C, E; L
Valsta: C, E, F; I Verkooijen: C, E; MO Weickert: C, E; A Weseler: C, E, F;
P Wilke: C, E; J Zhang: C, E, F.
Author statements of conflicts of interest are as follows. TMS Wolever: I
am president and part-owner of Glycemic Index Laboratories Inc, a contract
research organization and president and part-owner of Glycaemic Index
255S
256S
WOLEVER ET AL
REFERENCES
1. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett
WC. Dietary fiber, glycemic load and risk of non-insulin-dependent
diabetes mellitus in women. JAMA 1997;277:4727.
2. Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load,
and risk of NIDDM in men. Diabetes Care 1997;20:54550.
3. Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary
glycemic load, carbohydrate intake and risk of coronary heart disease in
US women. Am J Clin Nutr 2000;71:1455 61.
4. Frost G, Leeds A, Dor CJ, Madeiros S, Brading S, Dornhorst A. Glycaemic index as a determinant of serum HDL-cholesterol concentration.
Lancet 1999;353:1045 8.
5. McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PWF, Jacques PF.
Carbohydrate nutrition, insulin resistance, and the prevalence of the
metabolic syndrome in the Framingham Offspring cohort. Diabetes Care
2004;27:538 46.
6. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Rikder PM.
Relationship between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged
women. Am J Clin Nutr 2002;75:492 8.
7. Augustin LS, Dal Maso L, La Vecchia C, et al. Dietary glycemic index
and glycemic load, and breast cancer risk: a case-control study. Ann
Oncol 2001;12:1533 8.
8. Augustin LSA, Polesel J, Bosetti C, et al. Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy. Ann
Oncol 2003;14:78 84.
9. Augustin LSA, Gallus S, Bosetti C, et al. Glycemic index and glycemic
load in endometrial cancer. Int J Cancer 2003;105:404 7.
10. Augustin LSA, Gallus S, Franceschi S, et al. Glycemic index and load
and risk of upper aero-digestive tract neoplasms (Italy). Cancer Causes
Control 2004;14:657 62.
11. Augustin LSA, Gallus S, Negri E, La Vecchia C. Glycemic index, glycemic load and risk of gastric cancer. Ann Oncol 2004;15:581 4.
12. Augustin LSA, Galeone C, Dal Maso L, et al. Glycemic index, glycemic
load and risk of prostate cancer. Int J Cancer 2004;112:446 50.
13. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index
diets in the management of diabetes: a meta-analysis of randomized
controlled trials. Diabetes Care 2003;26:22617.
14. Frost G, Leeds A, Trew G, Margara R, Dornhorst A. Insulin sensitivity
in women at risk of coronary heart disease and the effect of a low
glycemic diet. Metabolism 1998;47:124551.
15. Rizkalla SW, Taghrid L, Laromiguiere M, et al. Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a lowglycemic index diet in type 2 diabetic men: a randomized trial. Diabetes
Care 2004;27:1866 72.
16. Wolever TMS, Mehling C. High-carbohydrate/low-glycaemic index dietary advice improves glucose disposition index in subjects with impaired glucose tolerance. Br J Nutr 2002;87:477 87.
17. Juntunen KS, Laaksonen DE, Poutanen KS, Niskanen LK, Mykkanen
HM. High-fiber rye bread and insulin secretion and sensitivity in healthy
postmenopausal women. Am J Clin Nutr 2003;77:38591.
18. Warren JM, Henry CJK, Simonite V. Low glycemic index breakfasts and
reduced food intake in preadolescent children. Pediatrics [serial online]
2003;112:e414. Internet: http://www.pediatrics.org/cgi/content/full/
112/5/e414 (accessed 16 February 2007).
19. Slabber M, Barnard HC, Kuyl JM, Dannhauser A, Schall R. Effects of
low-insulin-response, energy-restricted diet on weight loss and plasma
insulin concentrations in hyperinsulinemic obese females. Am J Clin
Nutr 1994;60:48 53.
20. Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS. A
reduced-glycemic load diet in the treatment of adolescent obesity. Arch
Pediatr Adolesc Med 2003;157:7739.
21. McMillan-Price J, Petocz P, Atkinson F, et al. Comparison of 4 diets of
varying glycemic load on weight loss and cardiovascular risk reduction
in overweight and obese young adults. Arch Intern Med 2006;166:1466
75.
22. Kaplan RJ, Greenwood CE, Winocur G, Wolever TMS. Cognitive performance is associated with glucose regulation in healthy elderly persons
and can be enhanced with glucose and dietary carbohydrates. Am J Clin
Nutr 2000;72:82536.
23. Benton D, Ruffin MP, Lassel T, et al. The delivery rate of dietary
carbohydrates affects cognitive performance in both rats and humans.
Psychopharmacol 2003;166:86 90.
24. Kelly S, Frost G, Whittaker V, Summerbell C. Low glyacemic index
diets for coronary heart disease. Cochrane Database Syst Rev 2004;4:
CD004467.
25. Nutrition Subcommittee of the Diabetes Care Advisory Committee of
Diabetes UK. The implementation of nutritional advice for people with
diabetes. Diabetic Med 2003;20:786 807.
26. Wolever TMS, Gourgeon R, Freeze C, Field C, Thongthai K, Canadian
Diabetes Association Clinical Practice Guidelines Expert Committee.
Canadian Diabetes Association 2003 clinical practice guidelines for the
27.
28.
29.
30.
31.
32.
33.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
prior diet and activities does not reduce within-subject variation of postprandial glycemic responses to foods. Nutr Res 2003;23:6219.
Wolever TMS, Gibbs AL, Spolar M, Hitchner EV, Heimowitz C. Equivalent glycemic load (EGL): a method for quantifying the glycemic responses elicited by low carbohydrate foods. Nutr Metab (Lond) 2006;
3:33.
Siler SQ, Neese RA, Christiansen MP, Hellerstein MK. The inhibition of
gluconeogenesis following alcohol in humans. Am J Physiol 1998;275:
E897907.
Shelmet JJ, Reichard GA, Skutches CL, Hoeldtke RD, Owen OE, Boden
G. Ethanol causes acute inhibition of carbohydrate, fat and protein oxidation and insulin resistance. J Clin Invest 1988;81:1137 45.
Mikines KJ, Sonne B, Farrell PA, Tronier B, Galbo H. Effect of physical
exercise on sensitivity and responsiveness to insulin in humans. Am J
Physiol 1988;254:E248 59.
Malkova D, Evans RD, Frayn KN, Humphreys SM, Jones PR, Hardman
AE. Prior exercise and postprandial substrate extraction across the human leg. Am J Physiol 2000;279:E1020 8.
Goulet ED, Melanon MO, Aubertin-Leheudre M, Dionne IJ. Aerobic
training improves insulin sensitivity 72120h after the last exercise
session in younger but not in older women. Eur J Appl Physiol 2005;
95:146 52.
Moghaddam E, Vogt JA, Wolever TMS. The effects of fat and protein on
glycemic responses in nondiabetic humans vary with waist circumference, fasting plasma insulin, and dietary fiber intake. J Nutr 2006;136:
2506 11.
Weickert MO, Mohlig M, Koebnick C, et al. Impact of cereal fibre on
glucose-regulating factors. Diabetologia 2005;48:234353.
Brand-Miller JC, Colagiuri S, Gan ST. Insulin sensitivity predicts glycemia after a protein load. Metabolism 2000;49:15.
Cunningham KM, Daly J, Horowitz M, Read NW. Gastrointestinal adaptation to diets of differing fat composition in human volunteers. Gut
1991;32:483 6.
Battram DS, Arthur R, Weekes A, Graham TE. The glucose intolerance
induced by caffeinated coffee ingestion is less pronounced than that due
to alkaloid caffeine in men. J Nutr 2006;136:1276 80.
Velangi A, Fernandes G, Wolever TMS. Evaluation of a glucose meter
for determining the glycemic responses of foods. Clin Chim Acta 2005;
356:191 8.
Engel L, Delaney C, Cohen M. Blood glucose meters: an independent
head-to-head comparison. Pract Diabetes Int 1998;15:15 8.
Wolever TMS, Ip B, Moghaddam E. Measuring glycaemic responses:
duplicate fasting samples or duplicate measures of one fasting sample?
Br J Nutr 2006;96:799 802.
Robertson MD, Henderson RA, Vist GE, Rumsey RDE. Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism. Am J Clin Nutr 2002;75:50510.
stman E, Presten T, Bjrk I. Effects of GI and
Nilsson A, Granfeldt Y, O
content of indigestible carbohydrates of cereal-based evening meals on
glucose tolerance at a subsequent standardized breakfast. Eur J Clin Nutr
2006;60:10929.
34.
257S